Product Name

  • Name

    Letrozole

  • EINECS 675-034-8
  • CAS No. 112809-51-5
  • Article Data34
  • CAS DataBase
  • Density 1.21g/cm3
  • Solubility
  • Melting Point 100-102 °C
  • Formula C17H11N5
  • Boiling Point 374.4 °C at 760 mmHg
  • Molecular Weight 285.308
  • Flash Point 180.3 °C
  • Transport Information
  • Appearance white to off-whitecrystalline powder
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 112809-51-5 (Letrozole)
  • Hazard Symbols IrritantXi
  • Synonyms 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
  • PSA 78.29000
  • LogP 2.65916

Synthetic route

4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile hydrochloride
112809-26-4

4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile hydrochloride

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile hydrochloride With potassium tert-butylate In N,N-dimethyl-formamide at -25 - -20℃; for 1.08333h; Inert atmosphere;
Stage #2: 4-fluorobenzonitrile In N,N-dimethyl-formamide at -25 - -20℃; for 1.08333h;
98.6%
Stage #1: 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile hydrochloride With potassium tert-butylate In N,N-dimethyl-formamide at -25 - -20℃; for 1.08333h;
Stage #2: 4-fluorobenzonitrile In N,N-dimethyl-formamide at -25 - -20℃; for 1.08333h;
Stage #3: With hydrogenchloride In water; N,N-dimethyl-formamide at -20 - 0℃; for 0.5h; pH=6.0 - 6.5; Product distribution / selectivity;
55%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

toluene-4-sulfonic acid bis-(4-cyano-phenyl)-methyl ester
935477-95-5

toluene-4-sulfonic acid bis-(4-cyano-phenyl)-methyl ester

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 1,2,4-Triazole With tetrabutylammomium bromide; potassium carbonate In water; 4-methyl-2-pentanone for 2h;
Stage #2: toluene-4-sulfonic acid bis-(4-cyano-phenyl)-methyl ester In water; 4-methyl-2-pentanone at 20 - 30℃; for 48h;
Stage #3: With hydrogenchloride In water; 4-methyl-2-pentanone for 1h;
97.42%
potassium cyanide

potassium cyanide

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: potassium cyanide With acetic acid In ethylene glycol Sealed tube;
Stage #2: 1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole With P(t-Bu)3 Palladacycle Gen. 3; potassium acetate In 1,4-dioxane; water at 60℃; for 16h; Concentration; Sealed tube;
97%
4-((4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl)benzamide

4-((4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl)benzamide

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With trifluoroacetic anhydride In 1,4-dioxane at 0 - 20℃; for 1h;90%
4-amino-1,2,4-triazole
584-13-4

4-amino-1,2,4-triazole

4,4'-dicyanodiphenylbromomethane
69545-39-7

4,4'-dicyanodiphenylbromomethane

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-amino-1,2,4-triazole; 4,4'-dicyanodiphenylbromomethane In acetonitrile for 24h; Reflux;
Stage #2: With hydrogenchloride; sodium nitrite In water; acetonitrile at 0 - 5℃; for 6h; Solvent; Time;
88.7%
potassiumhexacyanoferrate(II) trihydrate

potassiumhexacyanoferrate(II) trihydrate

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With sodium carbonate In water; N,N-dimethyl-formamide at 120℃; for 24h;87%
zinc cyanide

zinc cyanide

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

1-(bis(4-bromophenyl)methyl)-1H-1,2,4-triazole

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With 1,1'-bis-(diphenylphosphino)ferrocene; water; bis(dibenzylideneacetone)-palladium(0) In N,N-dimethyl-formamide at 120℃; for 15h; Inert atmosphere;86%
4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

sodium triazole
41253-21-8

sodium triazole

4-cyanobenzyl bromide
17201-43-3

4-cyanobenzyl bromide

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: sodium triazole; 4-cyanobenzyl bromide With potassium tert-butylate In N,N-dimethyl-formamide at -5 - 5℃; for 2.5h;
Stage #2: 4-fluorobenzonitrile In N,N-dimethyl-formamide at -5 - 5℃; for 2.5h; Product distribution / selectivity;
85%
Stage #1: sodium triazole; 4-cyanobenzyl bromide In N,N-dimethyl-formamide at -10 - 0℃; for 1h;
Stage #2: 4-fluorobenzonitrile With sodium hexamethyldisilazane In tetrahydrofuran; N,N-dimethyl-formamide at -10 - -5℃; Product distribution / selectivity;
Stage #1: sodium triazole; 4-cyanobenzyl bromide In ISOPROPYLAMIDE at -15 - 0℃; for 2.5h;
Stage #2: 4-fluorobenzonitrile With sodium hexamethyldisilazane In tetrahydrofuran; ISOPROPYLAMIDE at -8 - 0℃; for 1h; Product distribution / selectivity;
C40H28ClN10Ru(1+)*BF4(1-)

C40H28ClN10Ru(1+)*BF4(1-)

triphenylphosphine
603-35-0

triphenylphosphine

A

C41H32ClN5PRu(1+)*BF4(1-)

C41H32ClN5PRu(1+)*BF4(1-)

B

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
In dichloromethane at 20℃; for 48h;A 75%
B n/a
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-(alpha-chloro-4'-cyanobenzyl)-benzonitrile
112809-57-1

4-(alpha-chloro-4'-cyanobenzyl)-benzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; toluene at 60 - 80℃; for 4h;74.4%
4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile With potassium tert-butylate In N,N-dimethyl-formamide at -5 - 0℃; for 2h;
Stage #2: 4-fluorobenzonitrile In N,N-dimethyl-formamide at 0 - 10℃; for 0.25h; Product distribution / selectivity;
73%
Stage #1: 4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile With lithium hexamethyldisilazane In tetrahydrofuran at -30 - -25℃; for 0.666667h;
Stage #2: 4-fluorobenzonitrile In tetrahydrofuran at -20 - -15℃; for 1.25h; Product distribution / selectivity;
1,3,5-Triazine
290-87-9

1,3,5-Triazine

2-(propan-2-ylidine)-1-[di-(4-cyanophenyl)methyl]hydrazine
1280504-38-2

2-(propan-2-ylidine)-1-[di-(4-cyanophenyl)methyl]hydrazine

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 2-(propan-2-ylidine)-1-[di-(4-cyanophenyl)methyl]hydrazine With hydrogenchloride In methanol at 20℃;
Stage #2: 1,3,5-Triazine In methanol Reflux;
70.7%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4,4'-dicyanodiphenylbromomethane
69545-39-7

4,4'-dicyanodiphenylbromomethane

A

4-[α-(4-cyano-phenyl)-1-(1,3,4-triazol-1-yl)-methyl]-benzonitrile
112809-52-6

4-[α-(4-cyano-phenyl)-1-(1,3,4-triazol-1-yl)-methyl]-benzonitrile

B

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; toluene at 60 - 80℃; for 1.5h; Product distribution / selectivity;A 3.5%
B 70.5%
zinc(II) cyanide
557-21-1

zinc(II) cyanide

1--1H-1,2,4-triazole
102994-04-7

1--1H-1,2,4-triazole

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With dmap; 1,1'-bis-(diphenylphosphino)ferrocene; nickel(II) chloride hexahydrate; zinc In acetonitrile at 80℃; for 4h; Inert atmosphere; Sealed tube;68%
With dmap; 1,1'-bis-(diphenylphosphino)ferrocene; nickel(II) chloride hexahydrate; zinc In acetonitrile at 80℃; for 4h; Inert atmosphere; Glovebox; Sealed tube;68%
4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile
112809-25-3

4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile

2-(4-fluorobenzene)-1,3,4-oxadiazole
595567-05-8

2-(4-fluorobenzene)-1,3,4-oxadiazole

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile With potassium tert-butylate In N,N-dimethyl-formamide at -5℃; Inert atmosphere;
Stage #2: 2-(4-fluorobenzene)-1,3,4-oxadiazole In N,N-dimethyl-formamide at -5℃; for 7.5h; Inert atmosphere;
64%
4-[1-(1,2,4-triazol-1-yl)methyl] benzonitrile

4-[1-(1,2,4-triazol-1-yl)methyl] benzonitrile

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-[1-(1,2,4-triazol-1-yl)methyl] benzonitrile; 4-fluorobenzonitrile With potassium tert-butylate In DMF (N,N-dimethyl-formamide) at -10 - -5℃; for 4h;
Stage #2: With hydrogenchloride In DMF (N,N-dimethyl-formamide); water pH=7.5 - 8.0;
58%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-(bromomethyl)benzaldehyde
51359-78-5

4-(bromomethyl)benzaldehyde

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-(bromomethyl)benzaldehyde; 4-chlorobenzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 12h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
43%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-(bromomethyl)benzaldehyde
51359-78-5

4-(bromomethyl)benzaldehyde

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-(bromomethyl)benzaldehyde; 4-bromo-benzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 10h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
35%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-chloromethylbenzaldehyde
73291-09-5

4-chloromethylbenzaldehyde

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-chloromethylbenzaldehyde; 4-chlorobenzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 10h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
34%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-chloromethylbenzaldehyde
73291-09-5

4-chloromethylbenzaldehyde

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-chloromethylbenzaldehyde; 4-bromo-benzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 10h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
33%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-iodomethylbenzaldehyde
112812-08-5

4-iodomethylbenzaldehyde

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-iodomethylbenzaldehyde; 4-bromo-benzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 10h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
32%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-(bromomethyl)benzaldehyde
51359-78-5

4-(bromomethyl)benzaldehyde

4-fluorobenzaldehyde
459-57-4

4-fluorobenzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-(bromomethyl)benzaldehyde; 4-fluorobenzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 12h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
32%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-iodomethylbenzaldehyde
112812-08-5

4-iodomethylbenzaldehyde

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
Stage #1: 4-iodomethylbenzaldehyde; 4-chlorobenzaldehyde With ammonium hydroxide; copper diacetate In dimethyl sulfoxide at 70℃; for 10h;
Stage #2: 1,2,4-Triazole With potassium carbonate; potassium iodide In dimethyl sulfoxide; acetone at 50℃; for 10h; Inert atmosphere;
21%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4,4'-dicyanodiphenylbromomethane
69545-39-7

4,4'-dicyanodiphenylbromomethane

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In isopropyl alcohol for 8 - 9h; Product distribution / selectivity; Heating / reflux;
With potassium carbonate In isopropyl alcohol for 8 - 9h; Product distribution / selectivity; Heating / reflux;
4-[1-(1,2,4-triazolyl)methyl]-benzonitrile

4-[1-(1,2,4-triazolyl)methyl]-benzonitrile

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With potassium tert-butylate In N-methyl-acetamide
4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile
112809-25-3

4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran at -15℃; for 7 - 8h; Product distribution / selectivity;
With lithium hexamethyldisilazane In tetrahydrofuran at -20 - -5℃; for 2h; Product distribution / selectivity;
Stage #1: 4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile With potassium tert-butylate In N,N-dimethyl-formamide at 0 - 5℃; for 1.5h;
Stage #2: 4-fluorobenzonitrile In N,N-dimethyl-formamide at 0 - 5℃; for 1.5h;
4-[(1-(1,3,4-triazolyl)-methyl)]benzonitrile
112809-27-5

4-[(1-(1,3,4-triazolyl)-methyl)]benzonitrile

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile
112809-25-3

4-((1H-1,2,4-triazole-1-yl)methyl)benzonitrile

A

4-[α-(4-cyano-phenyl)-1-(1,3,4-triazol-1-yl)-methyl]-benzonitrile
112809-52-6

4-[α-(4-cyano-phenyl)-1-(1,3,4-triazol-1-yl)-methyl]-benzonitrile

B

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran at -15℃; for 3h; Product distribution / selectivity;
α-(1H-[1,2,4]triazol-1-yl)-4,4'-diformaldoxime-diphenylmethane

α-(1H-[1,2,4]triazol-1-yl)-4,4'-diformaldoxime-diphenylmethane

letrozol
112809-51-5

letrozol

Conditions
ConditionsYield
With acetic anhydride for 8 - 10h; Product distribution / selectivity; Heating / reflux;
With sodium acetate; acetic anhydride; acetic acid at 20℃; for 3 - 4h; Product distribution / selectivity; Heating / reflux;
cobalt(II) chloride hexahydrate

cobalt(II) chloride hexahydrate

letrozol
112809-51-5

letrozol

CoCl2(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)*H2O

CoCl2(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)*H2O

Conditions
ConditionsYield
In ethanol; water High Pressure; mixt. of letrozole, CoCl2, EtOH and H2O sealed in stainless steel reactor, heated to 120°C for 24 h, slowly cooled to room temp.; elem. anal.;97.8%
In ethanol; water CoCl2 and letrozole dissolved in EtOH/H2O; mixt. stirred at room temp. for 1 h; filtered, soln. kept at room temp. for 4 d; elem. anal.;33.5%
letrozol
112809-51-5

letrozol

4,4′-(1H-1,2,4-triazol-1-yl)methylene-bis(benzoic acid)

4,4′-(1H-1,2,4-triazol-1-yl)methylene-bis(benzoic acid)

Conditions
ConditionsYield
Stage #1: letrozol With sodium hydroxide In water for 6h; Reflux;
Stage #2: With hydrogenchloride In water
94.9%
Stage #1: letrozol With potassium hydroxide In ethanol; water for 36h; Reflux;
Stage #2: With hydrogenchloride In water pH=2;
86.1%
Stage #1: letrozol With sodium hydroxide In N,N-dimethyl-formamide at 120℃; for 12h;
Stage #2: With hydrogenchloride In water; N,N-dimethyl-formamide pH=1;
77%
With [Rh(6,7-dihydrotribenzo-[e,i,m][1,4,7,12]-ioxadiazacyclotetradecine)]Cl; water; sodium hydroxide at 70℃; for 0.25h; Reagent/catalyst; Time;97.43 %Spectr.
Alkaline conditions;
nickel(II) chloride hexahydrate

nickel(II) chloride hexahydrate

letrozol
112809-51-5

letrozol

NiCl2(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)*H2O

NiCl2(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)*H2O

Conditions
ConditionsYield
In ethanol; water High Pressure; mixt. of letrozole, NiCl2, EtOH and H2O sealed in stainless steel reactor, heated to 120°C for 24 h, slowly cooled to room temp.; elem. anal.;94.8%
In ethanol; water NiCl2 and letrozole dissolved in EtOH/H2O; mixt. stirred at room temp. for 1 h; filtered, soln. kept at room temp. for 4 d; elem. anal.;45.3%
trans-Cl2Pd(H2NCH2C6H5)2
19046-92-5, 55176-74-4

trans-Cl2Pd(H2NCH2C6H5)2

silver nitrate

silver nitrate

letrozol
112809-51-5

letrozol

[Pd(PhCH2NH2)2(4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile)2](NO3)2

[Pd(PhCH2NH2)2(4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile)2](NO3)2

Conditions
ConditionsYield
Stage #1: trans-Cl2Pd(H2NCH2C6H5)2; silver nitrate In acetone at 25℃; for 2h; Darkness;
Stage #2: letrozol In acetone
78.5%
dichloro(benzene)ruthenium(II) dimer
37366-09-9

dichloro(benzene)ruthenium(II) dimer

ammonium tetrafluoroborate

ammonium tetrafluoroborate

letrozol
112809-51-5

letrozol

C40H28ClN10Ru(1+)*BF4(1-)

C40H28ClN10Ru(1+)*BF4(1-)

Conditions
ConditionsYield
In ethanol for 1h; Reflux;73%
letrozol
112809-51-5

letrozol

C17H15N5S2

C17H15N5S2

Conditions
ConditionsYield
With 2,3,4,5,7,8,9,10-octahydropyrimido[1,2-a]azepin-1-ium acetate; sodiumsulfide nonahydrate In neat (no solvent) at 20℃; for 2h; Green chemistry;73%
ethanol
64-17-5

ethanol

letrozol
112809-51-5

letrozol

diethyl 4,4′-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzenecarboximidate

diethyl 4,4′-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzenecarboximidate

Conditions
ConditionsYield
With acetyl chloride at 20℃; Cooling with ice;72%
Sodium trans-Bis(dimethhyl sulfoxide) tetrachlororuthenate(III)
131759-88-1, 61779-28-0

Sodium trans-Bis(dimethhyl sulfoxide) tetrachlororuthenate(III)

letrozol
112809-51-5

letrozol

Na[trans-RuCl4(letrozole)(dimethyl sulfoxide)]

Na[trans-RuCl4(letrozole)(dimethyl sulfoxide)]

Conditions
ConditionsYield
In acetone Inert atmosphere; Schlenk technique;66%
letrozol
112809-51-5

letrozol

C17H13N5S

C17H13N5S

Conditions
ConditionsYield
With 2,3,4,5,7,8,9,10-octahydropyrimido[1,2-a]azepin-1-ium acetate; sodiumsulfide nonahydrate In neat (no solvent) at 20℃; for 2h; Green chemistry;64%
letrozol
112809-51-5

letrozol

4,4'-dicyanodiphenylmethane
10466-37-2

4,4'-dicyanodiphenylmethane

Conditions
ConditionsYield
With tetraethylammonium perchlorate; triethylamine In dimethyl sulfoxide at 20℃; for 6h; Electrolysis; Green chemistry;55%
copper(II) choride dihydrate

copper(II) choride dihydrate

letrozol
112809-51-5

letrozol

[Cu(1-[bis(4-cyano-phenyl)methyl]-1,2,4-triazole)3Cl2]

[Cu(1-[bis(4-cyano-phenyl)methyl]-1,2,4-triazole)3Cl2]

Conditions
ConditionsYield
In ethanol; water at 120℃; for 72h;47%
tetrakis(acetonitrile)copper(I)tetrafluoroborate

tetrakis(acetonitrile)copper(I)tetrafluoroborate

chloroform
67-66-3

chloroform

letrozol
112809-51-5

letrozol

Cu(I)(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)BF4*CHCl3
364594-74-1

Cu(I)(1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole)BF4*CHCl3

Conditions
ConditionsYield
In chloroform; benzene solvothermal treatment of Cu-complex with ligand in benzene and CHCl3 for 3 ds at 100°C; elem. anal.;40%

Letrozole Specification

1. Introduction of Letrozole
Letrozole is one kind of white to off-whitecrystalline powder. The IUPAC Name of this chemical is 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile. Letrozole belongs to Anti-Cancer;Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Letrozole;Antineoplastic;All Inhibitors;anti-neoplastic;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;APIs;Antibiotics;Aromatics;Heterocycles. 

Besides, its Classification Code is Antineoplastic; Antineoplastic agents; Aromatase Inhibitors; Enzyme inhibitors. In addition, Letrozole is freely soluble in dichloromethane, slightly soluble in ethanol, and practically insoluble in water.

2. Properties of Letrozole
Physical properties about Letrozole are:
(1)Molecular Weight: 285.30274 g/mol; (2)Molecular Formula: C17H11N5; (3)XLogP3-AA: 2.7; (4)H-Bond Donor: 0; (5)H-Bond Acceptor: 4.

3. Structure Descriptors of Letrozole
(1)InChI: InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H
(2)InChIKey: HPJKCIUCZWXJDR-UHFFFAOYSA-N
(3)Canonical SMILES: C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
(4)Smiles: n1(C(c2ccc(cc2)C#N)c2ccc(cc2)C#N)ncnc1

4. Uses of Letrozole
Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medications such as bisphosphonates.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View